List of Excipients in API diazoxide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing diazoxide
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | ALCOHOL | |
Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | CARBOXYMETHYLCELLULOSE SODIUM | |
Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | HYDROCHLORIC ACID | |
Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | MAGNESIUM ALUMINUM SILICATE | |
Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | METHYLPARABEN | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing diazoxide
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 | ALCOHOL |
Par Pharmaceutical Inc | diazoxide | 0254-1010 | CARBOXYMETHYLCELLULOSE SODIUM |
Par Pharmaceutical Inc | diazoxide | 0254-1010 | FD&C RED NO. 40 |
Par Pharmaceutical Inc | diazoxide | 0254-1010 | FD&C YELLOW NO. 6 |
Par Pharmaceutical Inc | diazoxide | 0254-1010 | HYDROCHLORIC ACID |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for diazoxide
Excipient focus: ALCOHOL
diazoxide drug variants containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing ALCOHOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
diazoxide drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
diazoxide drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
diazoxide drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
diazoxide drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM ALUMINUM SILICATE
diazoxide drug variants containing MAGNESIUM ALUMINUM SILICATE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing MAGNESIUM ALUMINUM SILICATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
diazoxide drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
diazoxide drug variants containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
diazoxide drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE OXIDE
diazoxide drug variants containing PROPYLENE OXIDE
Company | Ingredient | NDC |
---|---|---|
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing PROPYLENE OXIDE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
diazoxide drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
diazoxide drug variants containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
diazoxide drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
diazoxide drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL SOLUTION 70%
diazoxide drug variants containing SORBITOL SOLUTION 70%
Company | Ingredient | NDC |
---|---|---|
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing SORBITOL SOLUTION 70%
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
diazoxide drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | diazoxide | 0254-1010 |
Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
e5 Pharma LLC | diazoxide | 13517-100 |
>Company | >Ingredient | >NDC |
diazoxide drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.